Agenus
Agenus's Overview
Agenus is a clinical-stage immuno-oncology company focused on the discovery and development of transformative medicines that engage the body's immune system to fight cancer and infections. With a comprehensive portfolio of antibodies, including checkpoint inhibitors, bispecific antibodies, and cellular therapies, Agenus aims to deliver innovative solutions for patients. The company leverages its proprietary antibody discovery platforms and manufacturing capabilities to advance its pipeline of novel immunotherapies. Agenus's QS-21 Stimulon™ adjuvant is a key component in multiple partnered vaccines.
Where is Agenus's Headquarters?
HQ Function
The Lexington headquarters serves as the central hub for Agenus's corporate operations, research and development activities, and strategic decision-making.
Notable Features:
State-of-the-art laboratory facilities for drug discovery and development, modern office spaces designed for collaboration.
Work Culture:
Agenus fosters an innovative, science-driven, and collaborative work environment. Employees are dedicated to advancing cutting-edge immuno-oncology therapies. The culture encourages intellectual curiosity and a patient-focused approach.
HQ Significance:
The Lexington HQ is strategically located within one of the world's leading biotechnology clusters, facilitating access to talent, research institutions, and industry partners.
Values Reflected in HQ: The headquarters reflects Agenus's core values of innovation, scientific excellence, collaboration, and a commitment to improving patient lives.
Location:
Agenus operates globally with key functions including research and development, clinical trial management, manufacturing, and business development. Its presence in North America and Europe allows for strategic collaborations, diverse clinical trial populations, and access to global talent and markets in the immuno-oncology field.
Street Address:
3 Forbes Road
City:
Lexington
State/Province:
MA
Country:
USA
Agenus's Global Presence
Berkeley, CA, USA
Address: 2000 Carleton Street, Berkeley, CA 94710, USA
Leverages the San Francisco Bay Area's rich biotech ecosystem for talent and innovation in early-stage R&D and cell therapy.
Cambridge, UK
Address: Granta Park, Great Abington, Cambridge, CB21 6GP, UK
Serves as a key site for managing European clinical trials and engaging with the European life sciences community.
Liège, Belgium
Address: Agenus SA, Rue des Chasseurs Ardennais, Parc CREALYS, 5020 Suarlée (Namur), Belgium
Critical for the global supply chain of QS-21, supporting partnered vaccine programs and internal development.
Buying Intent Signals for Agenus
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Agenus
As of April 2025, Agenus' leadership includes:
Investors of Agenus
Agenus has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
In the last 12 months, Agenus announced the appointment of Dr. Marc Eltoft as Chief Regulatory Officer, strengthening its regulatory capabilities. No other major executive departures from the core leadership team have been publicly highlighted during this period.
New Appointments:
Technology (Tech Stack) used by Agenus
Discover the tools Agenus uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Agenus Email Formats and Examples
Agenus commonly uses the [first_initial][last_name]@agenusbio.com or [first_name].[last_name]@agenusbio.com email format. These are standard professional email structures.
[first_initial][last_name]@agenusbio.com or [first_name].[last_name]@agenusbio.com
Format
jdoe@agenusbio.com or jane.doe@agenusbio.com
Example
85%
Success rate
News and media
Agenus Press Release • May 30, 2024
Agenus to Present at Upcoming Investor Conferences in June 2024
Agenus announced its participation in multiple investor conferences in June 2024, where company leadership will provide updates on its clinical programs and corporate strategy....more
Agenus Press Release • May 9, 2024
Agenus Reports First Quarter 2024 Financial Results and Provides Corporate Update
Agenus reported its financial results for the first quarter of 2024, highlighting progress in its botensilimab/balstilimab (BOT/BAL) clinical development program and other pipeline advancements....more
Agenus Press Release • April 4, 2024
Agenus to Present Botensilimab/Balstilimab Data in Non-MSI-H Colorectal Cancer at the 2024 ASCO Annual Meeting
Agenus announced it would present updated clinical data for its BOT/BAL combination therapy in patients with non-microsatellite instability-high (non-MSI-H) metastatic colorectal cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Agenus, are just a search away.